These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3927272

  • 41. Oral carotenoid treatment in polymorphous light eruption: a cross-over comparison with oxychloroquine and placebo.
    Jansén CT.
    Photodermatol; 1985 Jun; 2(3):166-9. PubMed ID: 3895186
    [Abstract] [Full Text] [Related]

  • 42. Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes.
    Bluhm R, Branch R, Johnston P, Stein R.
    JAMA; 1990 Sep 05; 264(9):1141-2. PubMed ID: 2117075
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Idiopathic canthaxanthine retinopathy.
    Sharkey JA.
    Eur J Ophthalmol; 1993 Sep 05; 3(4):226-8. PubMed ID: 8142748
    [Abstract] [Full Text] [Related]

  • 45. The effects of canthaxanthin on the photocutaneous manifestations of porphyria.
    Eales L.
    S Afr Med J; 1978 Dec 16; 54(25):1050-2. PubMed ID: 371027
    [Abstract] [Full Text] [Related]

  • 46. Canthaxanthin.
    Gupta AK, Haberman HF, Pawlowski D, Shulman G, Menon IA.
    Int J Dermatol; 1985 Oct 16; 24(8):528-32. PubMed ID: 3934089
    [Abstract] [Full Text] [Related]

  • 47. Canthaxanthine retinopathy.
    Espaillat A, Aiello LP, Arrigg PG, Villalobos R, Silver PM, Cavicchi RW.
    Arch Ophthalmol; 1999 Mar 16; 117(3):412-3. PubMed ID: 10088829
    [No Abstract] [Full Text] [Related]

  • 48. Absence of crystalline retinopathy after long-term therapy with beta-carotene.
    Poh-Fitzpatrick MB, Barbera LG.
    J Am Acad Dermatol; 1984 Jul 16; 11(1):111-3. PubMed ID: 6736346
    [Abstract] [Full Text] [Related]

  • 49. beta-Carotene in the treatment of erythropoietic protoporphyria. A short review.
    Krook G, Haeger-Aronsen B.
    Acta Derm Venereol Suppl (Stockh); 1982 Jul 16; 100():125-9. PubMed ID: 6819749
    [Abstract] [Full Text] [Related]

  • 50. Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes.
    Weber U, Michaelis L, Kern W, Goerz G.
    Graefes Arch Clin Exp Ophthalmol; 1987 Jul 16; 225(5):346-50. PubMed ID: 3117623
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro), in treatment of polymorphous light eruptions.
    Suhonen R, Plosila M.
    Dermatologica; 1981 Jul 16; 163(2):172-6. PubMed ID: 6793418
    [Abstract] [Full Text] [Related]

  • 54. [Actinic reticulosis (author's transl)].
    Laugier P.
    Ther Umsch; 1982 Mar 16; 39(3):167-72. PubMed ID: 6806929
    [No Abstract] [Full Text] [Related]

  • 55. Canthaxanthin toxicity.
    Herbert V.
    Am J Clin Nutr; 1991 Feb 16; 53(2):573-4. PubMed ID: 1899175
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Treatment of photosensitive American Indians with oral beta carotene.
    Fusaro RM, Johnson JA.
    JAMA; 1980 Jan 18; 243(3):231. PubMed ID: 7350368
    [No Abstract] [Full Text] [Related]

  • 58. [Crystalline retinopathy].
    Rasquin F.
    Bull Soc Belge Ophtalmol; 2007 Jan 18; (304):77-82. PubMed ID: 17718231
    [Abstract] [Full Text] [Related]

  • 59. Prevention of the benzo(a)pyrene photocarcinogenic effect by beta-carotene and canthaxanthine. Preliminary study.
    Santamaria L, Bianchi A, Arnaboldi A, Andreoni L.
    Boll Chim Farm; 1980 Dec 18; 119(12):745-8. PubMed ID: 6261777
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.